Skip to main content

Evonik expands in Asian alkoxides

Evonik has begun construction of a new production plant for alkoxides on Jurong Island in Singapore. Described as a “mid double-digit million-euro investment” this will complement sites in Germany, Argentina and the US, supplying the growing Asia-Pacific market when it comes onstream at the end of 2024. The aim is to achieve zero Scope 1 and 2 carbon emissions.

Singapore advance for Brenntag

Brenntag has opened its new pharmaceutical application development centre in the Singapore Science Park. This will be the company’s first pharma R&D facility anywhere, as well as part of Brenntag Specialties’ global network of 82 innovation and application development centres.

“Singapore is an ideal location for our first pharmaceutical application development centre, given its thriving ecosystem of R&D partners, technology providers and talent,” said Romain Girard, president of pharma Asia-Pacific at Brenntag Specialties. T

Toray opens Singapore centre

Japan’s Toray Industries has announced that it opened a research centre in Singapore in June. The centre is carrying out R&D into ‘electronic information materials’ and providing technical support in Southeast Asia. The company as a whole is seeking to build a global R&D structure spanning Japan, Korea and China.

Singapore site for WuXi AppTec

WuXi AppTec has announced a plan to build a new R&D and manufacturing site in Singapore at a cost of up to $1.4 billion. It will be created in stages over the next ten years, depending on the company’s business needs.

The company added that the site will serve “a critical role in its global network across Asia, Europe and North America”. It ill include “laboratories and facilities that provide a broad portfolio of R&D and manufacturing services” for the pharmaceutical industry.

Subscribe to Singapore